R&G PharmaStudies(301333.SZ) shareholder Harmony Growth Phase II and Harmony Health have collectively reduced their holdings by 2.1262 million shares.

date
22:08 06/03/2025
avatar
GMT Eight
Norsafe (301333.SZ) announcement, the company has received the "Notice on Reducing Holdings..." issued by Harmony Growth Phase II and Harmony Health.
R&G PharmaStudies (301333.SZ) announced that the company has received a notification letter from Harmony Growth Phase II and Harmony Health stating the implementation status of the reduction plan upon its completion. The above-mentioned shareholders collectively reduced their holdings of the company's shares by 2.1262 million shares.